Assessing Recent Efforts to Improve Organization of Cancer Care in Poland: What Does the Evidence Tell Us?


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
30 07 2022
Historique:
received: 30 06 2022
revised: 26 07 2022
accepted: 27 07 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 16 8 2022
Statut: epublish

Résumé

Poland has implemented two major organizational changes in recent years to improve cancer care. In 2015, a dedicated 'fast pathway' to diagnostics and treatment was implemented for patients suspected of having cancer. In 2019, the National Oncology Network began pilots in four regions of care pathways for cancer at five sites. Neither has been evaluated-no baseline information was collected, and what assessments were undertaken were limited to process measures. While the 2019 initiative was at least piloted, a national rollout has been announced even while the pilot is still ongoing and when concerns about certain aspects of the model have been raised. Given that cancer is the second largest cause of death in Poland and that cancer outcomes are worse compared to Western European averages, there is a particular need to ensure that models of care are informed by the evidence and adapted to the realities of the Polish healthcare system.

Identifiants

pubmed: 35954721
pii: ijerph19159369
doi: 10.3390/ijerph19159369
pmc: PMC9368127
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Health Policy. 2021 Feb;125(2):185-190
pubmed: 33298319
Health Policy. 2015 Mar;119(3):258-63
pubmed: 25659263
Front Public Health. 2018 Mar 20;6:82
pubmed: 29662876
Lancet Oncol. 2015 Mar;16(3):e104
pubmed: 25752556

Auteurs

Anna Sagan (A)

European Observatory on Health Systems and Policies, London School of Economics and Political Science, London WC2A 2AE, UK.
European Observatory on Health Systems and Policies, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

Iwona Kowalska-Bobko (I)

Institute of Public Health, Faculty of Health Sciences, Jagiellonian University, 31-067 Krakow, Poland.

Małgorzata Gałązka-Sobotka (M)

Institute of Healthcare Management, Faculty of Economics and Management, Lazarski University, 02-662 Warsaw, Poland.

Tomasz Holecki (T)

Department of Economic and Management in Healthcare, Faculty of Health Sciences in Bytom, University of Silesia in Katowice, 41-902 Bytom, Poland.

Adam Maciejczyk (A)

Lower Silesian Oncology Centre, 53-413 Wroclaw, Poland.

Martin McKee (M)

European Observatory on Health Systems and Policies, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH